^
Association details:
Biomarker:No biomarker
Cancer:Ovarian Serous Adenocarcinoma
Drug:carboplatin (Alkylating agent) +
docetaxel (Microtubule inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Low-grade serous (stage IC)/Grade I endometrioid (stage IC)....Other recommended regimens modified (Also for Stage II-IV disease on OV-C 6 of 11):...Docetaxel/carboplatin ± maintenance letrozole (category 2B) or other hormonal therapy (category 2B)